List of Tables
Table 1. List of secondary Sources
Table 2. List of abbreviations
Table 3. Global rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 4. Global rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 5. Global rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 6. Global rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 7. North America rare disease treatment, by region, 2018 - 2030 (USD Billion)
Table 8. North America rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 9. North America rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 10. North America rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 11. North America rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 12. U.S. rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 13. U.S. rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 14. U.S. rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 15. U.S. rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 16. Canada rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 17. Canada rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 18. Canada rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 19. Canada rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 20. Mexico rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 21. Mexico rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 22. Mexico rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 23. Mexico rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 24. Europe rare disease treatment, by country, 2018 - 2030 (USD Billion)
Table 25. Europe rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 26. Europe rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 27. Europe rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 28. Europe rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 29. UK rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 30. UK rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 31. UK rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 32. UK rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 33. Germany rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 34. Germany rare disease treatment, by drug 2018 - 2030 (USD Billion)
Table 35. Germany rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 36. Germany rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 37. France rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 38. France rare disease treatment, by drug 2018 - 2030 (USD Billion)
Table 39. France rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 40. France rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 41. Italy rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 42. Italy rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 43. Italy rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 44. Italy rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 45. Spain rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 46. Spain rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 47. Spain rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 48. Spain rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 49. Denmark rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 50. Denmark rare disease treatment, by drug 2018 - 2030 (USD Billion)
Table 51. Denmark rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 52. Denmark rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 53. Norway rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 54. Norway rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 55. Norway rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 56. Norway rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 57. Sweden rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 58. Sweden rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 59. Sweden rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 60. Sweden rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 61. Asia Pacific rare disease treatment, by country, 2018 - 2030 (USD Billion)
Table 62. Asia Pacific rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 63. Asia Pacific rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 64. Asia Pacific rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 65. Asia Pacific rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 66. Japan rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 67. Japan rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 68. Japan rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 69. Japan rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 70. China rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 71. China rare disease treatment, by drug 2018 - 2030 (USD Billion)
Table 72. China rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 73. China rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 74. India rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 75. India rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 76. India rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 77. India rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 78. Australia rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 79. Australia rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 80. Australia rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 81. Australia rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 82. South Korea rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 83. South Korea rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 84. South Korea rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 85. South Korea rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 86. Thailand rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 87. Thailand rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 88. Thailand rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 89. Thailand rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 90. Latin America rare disease treatment, by country, 2018 - 2030 (USD Billion)
Table 91. Latin America rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 92. Latin America rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 93. Latin America rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 94. Latin America rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 95. Brazil rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 96. Brazil rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 97. Brazil rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 98. Brazil rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 99. Argentina rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 100. Argentina rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 101. Argentina rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 102. Argentina rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 103. Middle East & Africa rare disease treatment, by country, 2018 - 2030 (USD Billion)
Table 104. Middle East & Africa rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 105. Middle East & Africa rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 106. Middle East & Africa rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 107. Middle East & Africa rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 108. South Africa rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 109. South Africa rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 110. South Africa rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 111. South Africa rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 112. Saudi Arabia rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 113. Saudi Arabia rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 114. Saudi Arabia rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 115. Saudi Arabia rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 116. UAE rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 117. UAE rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 118. UAE rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 119. UAE rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
Table 120. Kuwait rare disease treatment, by therapeutic area, 2018 - 2030 (USD Billion)
Table 121. Kuwait rare disease treatment, by drug, 2018 - 2030 (USD Billion)
Table 122. Kuwait rare disease treatment, by route of administration, 2018 - 2030 (USD Billion)
Table 123. Kuwait rare disease treatment, by distribution channel, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Rare disease treatment market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Rare disease treatment market: Therapeutic area outlook and key takeaways
Fig. 12 Cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 13 Neurological Conditions market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 14 Cardiovascular Conditions market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 15 Musculoskeletal Conditions market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 16 Hematologic Disorders market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 17 Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 18 Metabolic Disorders market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 19 Endocrine Disorders market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Rare disease treatment market: Drug outlook and key takeaways
Fig. 22 Rare disease treatment market: Drug movement analysis
Fig. 23 Biologics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Biosimilar market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Small molecules market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Rare Disease Treatment Market: Regional outlook and key takeaways
Fig. 27 Breast cancer liquid biopsy: Regional movement analysis
Fig. 28 Rare disease treatment market: Route of administration outlook and key takeaways
Fig. 29 Rare disease treatment market: Route of administration movement analysis
Fig. 30 Oral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Rare disease treatment market: Distribution channel outlook and key takeaways
Fig. 34 Rare disease treatment market: Distribution channel movement analysis
Fig. 35 Rare disease treatment market: regional key takeaways (USD billion)
Fig. 36 Rare disease treatment market: regional outlook, 2023 & 2030, USD billion
Fig. 37 North America rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 38 US rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 39 Canada rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 40 Mexico rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 41 Europe rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 42 UK rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 43 Germany rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 44 France rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 45 Spain rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 46 Italy rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 47 Norway rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 48 Denmark rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 49 Sweden rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 50 Asia Pacific rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 51 China rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 52 Japan rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 53 India rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 54 South Korea rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 55 Australia rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 56 Thailand rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 57 Latin America rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 58 Brazil rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 59 Argentina rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 60 Middle East and Africa rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 61 South Africa rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 62 Saudi Arabia rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 63 UAE rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 64 Kuwait rare disease treatment market estimates and forecasts, 2018 - 2030 (USD billion)
Fig. 65 List of key emerging company’s/technology disruptors/innovators
